An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
Authors
Jun Hao (ORCID: https://orcid.org/0000-0002-1213-0449)
Li Ma (ORCID: https://orcid.org/0000-0003-3212-0704)
Xiaolu Yang (ORCID: https://orcid.org/0000-0002-1716-5640)
Bei He (ORCID: https://orcid.org/0000-0002-3181-6614)
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
Jun Hao, Li Ma, Xiaolu Yang, Bei He et al.
Citations
3 citations
Journal
Frontiers in Immunology
Topics
Ferroptosis and cancer prognosis
Field-Weighted Citation Impact (FWCI)
4.56
article
An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis
Jun Hao, Li Ma, Xiaolu Yang, Bei He, Shiyu Zhang, Chang Yuan, Xiaolong Li, Tianqi Zhang, Cuizhi Geng, Yilun Li, Yunjiang Liu, Yaqi Peng
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Frontiers in ImmunologyVol. 16
Institutions
Hebei University of Engineering (CN), Hebei Medical University (CN), Fourth Hospital of Hebei Medical University (CN), Xingtai People's Hospital (CN), Affiliated Hospital of Hebei University (CN)